Gerald W. Crabtree

920 total citations
25 papers, 771 citations indexed

About

Gerald W. Crabtree is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Gerald W. Crabtree has authored 25 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Physiology and 7 papers in Epidemiology. Recurrent topics in Gerald W. Crabtree's work include Biochemical and Molecular Research (21 papers), Adenosine and Purinergic Signaling (10 papers) and Neonatal Health and Biochemistry (5 papers). Gerald W. Crabtree is often cited by papers focused on Biochemical and Molecular Research (21 papers), Adenosine and Purinergic Signaling (10 papers) and Neonatal Health and Biochemistry (5 papers). Gerald W. Crabtree collaborates with scholars based in United States and Canada. Gerald W. Crabtree's co-authors include Jane Henderson, Robert E. Parks, Alfred W. Senft, Todd M. Savarese, Eric Scholar, R. P. Agarwal, Khushboo Agarwal, Ram P. Agarwal, J. Arly Nelson and Paul Calabresi and has published in prestigious journals such as Journal of Clinical Investigation, Annals of the New York Academy of Sciences and Pharmacology & Therapeutics.

In The Last Decade

Gerald W. Crabtree

25 papers receiving 712 citations

Peers

Countries citing papers authored by Gerald W. Crabtree

Since Specialization

Citations

This map shows the geographic impact of Gerald W. Crabtree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald W. Crabtree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald W. Crabtree more than expected).

Fields of papers citing papers by Gerald W. Crabtree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald W. Crabtree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald W. Crabtree. The network helps show where Gerald W. Crabtree may publish in the future.

Co-authorship network of co-authors of Gerald W. Crabtree

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald W. Crabtree. A scholar is included among the top collaborators of Gerald W. Crabtree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald W. Crabtree. Gerald W. Crabtree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Site-Selective Cyclic AMP Analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene Regulation 1989 ·Cancer Investigation ·Yoon S. Cho‐Chung, Timothy Clair, P Tagliaferri, Shamsia Ally, Dionyssios Katsaros, Giampaolo Tortora, Leonard Μ. Neckers, Thomas L. Avery, Gerald W. Crabtree, Roland K. Robins	72
2	Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin 1988 ·Clinical Pharmacology & Therapeutics ·F J Cummings, Gerald W. Crabtree, Michael C. Wiemann, Ellen N. Spremulli, Robert E. Parks, Paul Calabresi	7
3	Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil 1988 ·Medical Oncology and Tumor Pharmacotherapy ·Michael C. Wiemann, Gerald W. Crabtree, Alan B. Weitberg, Ellen N. Spremulli, Frank J. Cummings, (unknown), Paul Calabresi	2
4	9-Deazaadenosine—A new potent antitumor agent 1984 ·Biochemical Pharmacology ·Ming Chu, (unknown), Seiji Sato, Gerald W. Crabtree, Arthur E. Bogdén, Mu‐Ill Lim, Robert S. Klein	35
5	A Therapeutic Monitoring Assay for N-Methylformamide in Human Serum and Urine 1983 ·Journal of Analytical Toxicology ·(unknown), (unknown), Daniel L. Dexter, Gerald W. Crabtree, Ellen N. Spremulli, Paul Calabresi, Israel Diamond	2
6	Purine metabolism in the schistosomes: Potential targets for chemotherapy 1983 ·Pharmacology & Therapeutics ·Alfred W. Senft, Gerald W. Crabtree	52
7	Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2′-deoxycoformycin(pentostatin) 1982 ·Biochemical Pharmacology ·Ellen N. Spremulli, Gerald W. Crabtree, Daniel L. Dexter, Shih Hsi Chu, (unknown), Lucy Ghoda, (unknown), Israel Diamond, Robert E. Parks, Paul Calabresi	8
8	N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cells. 1981 ·PubMed ·Daniel L. Dexter, Gerald W. Crabtree, Johanna D. Stoeckler, Todd M. Savarese, Lucy Ghoda, (unknown), Robert E. Parks, Paul Calabresi	36
9	A possible role for ecto-5'-nucleotidase in cytotoxicity and intra- cellular nucleotide formation from the tricyclic nucleoside-5'- -phosphate (tcn-p). Abstr. 1981 ·The Mouseion at the JAXlibrary (Jackson Laboratory) ·Linda L. Wotring, L B Townsend, Gerald W. Crabtree	3
10	Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumors 1981 ·Biochemical Pharmacology ·Gerald W. Crabtree, Daniel L. Dexter, Johanna D. Stoeckler, Todd M. Savarese, Lucy Ghoda, (unknown), Paul Calabresi, Robert E. Parks	16
11	Reaction of 5'-deoxyadenosine and related analogs with the 5'-methylthioadenosine cleaving enzyme of sarcoma 180 cells, a possible chemotherapeutic target enzyme 1979 ·Biochemical Pharmacology ·Todd M. Savarese, Gerald W. Crabtree, Robert E. Parks	39
12	N-methylformycins 1979 ·Biochemical Pharmacology ·Gerald W. Crabtree, Ram P. Agarwal, Robert E. Parks, (unknown), Linda L. Wotring, Leroy B. Townsend	14
13	Pathways of nucleotide metabolism in schistosoma mansoni—VII 1977 ·Biochemical Pharmacology ·Alfred W. Senft, Gerald W. Crabtree	24
14	Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency. 1976 ·Journal of Clinical Investigation ·R. P. Agarwal, Gerald W. Crabtree, Robert E. Parks, J. Arly Nelson, Richard G. Keightley, Robertson Parkman, Fred S. Rosen, Robert C. Stern, Stephen H. Polmar	68
15	Regulation of enzymes of purine metabolism in intact tumor cells 1975 ·Advances in Enzyme Regulation ·J. Frank Henderson, Aldo S. Bagnara, Gerald W. Crabtree, (unknown), Geraldine D. Shantz, Floyd F. Snyder	12
16	Pathways of nucleotide metabolism in Schistosoma mansoni—V Adenosine cleavage enzyme and effects of purine analogues on adenosine metabolism in vitro 1974 ·Biochemical Pharmacology ·Gerald W. Crabtree, Alfred W. Senft	24
17	Inhibition of purine biosynthesis de novo in sarcoma 180 ascites cells by mercapto and seleno purine analogs 1973 ·Biochemical Pharmacology ·Gerald W. Crabtree, Eric Scholar, S. Haihua Chu, Robert E. Parks	8
18	Pathways of nucleotide metabolism in Schistosoma mansoni—III 1973 ·Biochemical Pharmacology ·Alfred W. Senft, Gerald W. Crabtree, Kailash C. Agarwal, Eric Scholar, Ram P. Agarwal, Robert E. Parks	40
19	Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro. 1971 ·PubMed ·Gerald W. Crabtree, Jane Henderson	163
20	Pathways of Purine Ribonucleotide Catabolism in Ehrlich Ascites Tumor Cells In Vitro 1971 ·Canadian Journal of Biochemistry ·Gerald W. Crabtree, Jane Henderson	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact